Cooley advised Longboard Pharmaceuticals on the offering, and Latham & Watkins advised the underwriters involved.Longboard Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering…
Longboard Pharmaceuticals’ $20 Million Common Stock Offering
